PreciPoint is the world´s first full-solution provider for Digital Pathology offering all-in-one & end-2-end solutions to close the care gap
PreciPoint has raised $4.8M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
PreciPoint's investors include bm-t beteiligungsmanagement thuringen, Harmonix Fund.
PreciPoint is headquartered in Garching Bei München, Germany.
PreciPoint is the world´s first full-solution provider for Digital Pathology offering all-in-one & end-2-end solutions to close the care gap
PreciPoint is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PreciPoint — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/precipoint. Accessed August 14, 2026.
VCBacked. (2023). PreciPoint — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/precipoint
{{cite web |title=PreciPoint — Funding & Investors |url=https://www.vcbacked.co/company/precipoint |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated